Blood Test Could Guide Use of Anti-Inflammatory Drug Celecoxib to Reduce Risk of Colon Cancer Recurrence  | Newswise

Blood Test Could Guide Use of Anti-Inflammatory Drug Celecoxib to Reduce Risk of Colon Cancer Recurrence | Newswise

Newswise — Boston – A data analysis from a randomized clinical trial for stage 3 colon cancer patients by investigators at Dana-Farber Brigham Cancer Center found that patients with evidence of residual cancer in their blood after surgery to remove the cancer, may benefit from adding of celecoxib, to post surgery treatment. The analysis showed…

Read More
Blood Test Could Guide Use of Anti-Inflammatory Drug Celecoxib to Reduce Risk of Colon Cancer Recurrence  | Newswise

ARVO Foundation Names 2024 recipient of Kreissig Award for Excellence in Retinal Surgery | Newswise

Newswise — Rockville, Md.—The ARVO Foundation congratulates Mudit Tyagi, MD — 2024 recipient of the Kreissig Award for Excellence in Retinal Surgery. Established by Ingrid Kreissig, MD, through the ARVO Foundation, the $30,000 award recognizes excellence in the understanding of the mechanisms of retinal disease requiring surgical management, innovative approaches to management, and/or outcomes of…

Read More
Blood Test Could Guide Use of Anti-Inflammatory Drug Celecoxib to Reduce Risk of Colon Cancer Recurrence  | Newswise

Premier Plastic Surgery Partners Reveals the Top 5 Trends in Aesthetic Medicine for 2025 | Newswise

Newswise — LOS ANGELES, Jan. 3, 2025 /PRNewswire/ — The field of plastic surgery and aesthetic medicine continues to evolve, blending science, artistry, and technology to meet patient needs. As 2025 begins, the expert surgeons and founders of Premier Plastic Surgery Partners—Dr. Ross Clevens, Dr. Steven Ronan, and Dr. Jeffrey Spiegel—offer insights into the top…

Read More